A Randomized, Controlled, Parallel Study to Assess the Effects of Soy Protein on Body Composition and General Health Parameters in Healthy Children
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 1
- 主要终点
- change in body composition
研究概览
简要总结
The aim of this clinical trial is to assess the effects of daily consumption of soy protein foods on body composition, general health status and dietary intake outcomes in generally healthy children.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 8 Years 至 11 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject is male or female, 8-11 years of age, inclusive.
- •Subject is judged to be in good health on the basis of medical history.
- •Subject is a regular consumer (5 out of 7 d) of breakfast and snacks.
- •Subject has a BMI-for-age within the 75th and 95th percentile (Appendix 3).
- •Subject is willing to follow dietary changes consistent with the Dietary Guidelines for Americans 2010 throughout the study period (Appendix 5).
- •Subject/guardian understands the study procedures and signs forms providing assent/informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.
排除标准
- •Subject has a diagnosis of attention deficit disorder, with or without hyperactivity.
- •Subject requires special educational services related to cognitive or attentional disorders, neurologic diseases, and physical disabilities.
- •Subject is a girl who has begun menses.
- •Subject is at Tanner Stage IV or higher, as described by parent/guardian per self-assessment questionnaire (Appendix 2).
- •Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
- •Subject has a known allergy or sensitivity to the study foods.
- •Use of sleep aids within 2 weeks of visit 1 (week -1) and throughout the study.
- •Subject has extreme dietary habits, in the judgment of the Investigator.
- •Subject has used any weight loss supplements, programs, or meal replacement products (within 2 weeks of visit 1, week -1) intended to alter body weight (Appendix 1).
- •Subject has a history of an eating disorder (e.g., anorexia nervosa, bulimia nervosa or binge eating) diagnosed by a health professional.
- •Involvement in any clinical trial within 30 d prior to the screening visit.
- •Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.
研究组 & 干预措施
Usual Protein Group
Subjects will be instructed on the 2010 Dietary Guidelines for Americans including publically available information from the United States Department of Agricultural (USDA) MyPlate program (www.choosemyplate.gov). Subjects in this intervention group will not receive study provided foods.
干预措施: Dietary Guidance (Behavioral)
Soy Protein Group
Subjects will be instructed on the 2010 Dietary Guidelines for Americans including publically available information from the USDA MyPlate program (www.choosemyplate.gov) with the incorporation of two servings of study food providing soy protein per day.
干预措施: Soy protein containing foods (Other)
结局指标
主要结局
change in body composition
时间窗: week 0, week 12
DXA
次要结局
未报告次要终点